{
  "@context": "https://orbyd.app/schemas/dossier.v1.json",
  "ticker": "ELVR",
  "name": "Elevra Lithium Limited",
  "url": "https://orbyd.app/dossiers/ELVR/",
  "json_url": "https://orbyd.app/dossiers/ELVR.json",
  "status": "DORMANT",
  "current_conviction": "LOW",
  "graded_conviction": null,
  "archetype": {
    "code": "a1",
    "n": 1
  },
  "current_thesis": "Lithium-recovery narrative is broken: Q4 FY26 revenue US$31M (−61% QoQ) at a realized US$921/dmt as legacy pricing rolled off, and Guangzhou carbonate hit a five-month low CNY 136,800/t on 2026-07-22. The new fact is a divergence — the ADR held $60.34 (2026-08-07, RSI 58.8) without making new lows. Late-August FY26 results with first FY27 guidance resolve it.",
  "invalidation_trigger": "A weekly close below $55 confirms the July non-confirmation failed and the downtrend is intact; secondary break is FY26 full-year results in late August 2026 landing with FY27 spodumene guidance below FY26's ~197,968 dmt, or the NAL C$366M expansion deferred rather than sanctioned.",
  "catalyst_date": "2026-08-28",
  "outcome": "OPEN",
  "outcome_date": null,
  "invalidation_fired": null,
  "themes": [
    "critical-materials-rare-earths",
    "freight-logistics"
  ],
  "tags": [],
  "sources": [],
  "notes": [
    "ELVR is a thin Nasdaq ADR; ASX:ELV in AUD is the price-setting line and the ADR can dislocate from it on low volume.",
    "Australian issuer with a 30 June fiscal year end, reporting on Form 6-K. There is no US-style quarterly EPS event or conference-call cadence.",
    "Presentation currency was changed to USD, advised with the December 2025 quarterly report, so older AUD-denominated comparisons are not like-for-like.",
    "Revenue is realized-price driven with contractual pricing lags between spot spodumene and recognised price; volume records do not map to cash generation.",
    "Sell-side coverage is thin — roughly three analysts on the ASX line — so consensus targets move in large steps on single revisions.",
    "The Ewoyaa (Ghana) divestment to Zhejiang Huayou Cobalt for ~US$71M remains subject to completion, guided to Q3 CY26."
  ],
  "body_markdown": "## Current Thesis\nThe leg an investor would have been buying — a funded North American spodumene producer levered to a lithium price recovery — stopped working in July, and the June-quarter numbers explain why. The full Quarterly Activities Report (2026-07-28) put Q4 FY26 revenue at US$31M, down 61% QoQ, on sales of 33,977 dmt (−39% QoQ) at a realized US$921/dmt (−37% QoQ), while production rose 15% QoQ to 54,479 dmt at 5.0% grade. Legacy contract pricing rolled off; the realized number now sits close to a spot market that made a five-month low. The most-active Guangzhou lithium carbonate contract fell to CNY 136,800/t on 2026-07-22 before closing CNY 144,000 (−4.95% on the day), roughly 30% under the two-year high above CNY 200,000 set in mid-May 2026.\n\nWhat is genuinely new since the last update is a divergence: the commodity made a lower low on 2026-07-22, and the ADR did not follow it to new lows. The 2026-08-07 close of $60.34 is 3.7% under the $62.63 print of 2026-07-10, against a carbonate contract that fell far more over the same stretch, and RSI(14) sits at 58.8 with price 41.0% below the $102.33 52-week high. That is a bounce inside a downtrend with no confirmed base. Everything now points at the FY26 full-year result in late August, where the company said FY27 guidance will be given.\n\n## Bull Case\n- **Balance sheet is not the problem.** Cash of US$255M and net cash of US$200M at 30 June 2026, with the US$55M prepayment facility reduced by US$9M in July (Quarterly Activities Report, 2026-07-28). The May 2026 package — US$196M institutional placement, US$102M Canada Growth Fund convertible notes in two tranches, US$11M SPP — was raised before the price broke.\n- **NAL expansion economics were re-cut upward.** The updated North American Lithium study released with the 2026-07-28 report carries an incremental post-tax NPV8% of C$969M on C$366M of capex, on a staged approach the company says accelerates production growth by two years. Capex held flat while stated NPV more than doubled versus the prior study.\n- on 2026-08-07 Elevra completed the sale of its rights and obligations in E45/2364 to Wildcat for $16M plus an ongoing royalty.\n\n- **Offtake control at Moblan.** Elevra now controls 100% of its 60% pro rata offtake entitlement (2026-07-28 report), removing a counterparty claim on future tonnes.\n\n## Bear Case\n- Record volume did not defend cash generation.\n- **The pricing cushion is gone.** The 61% QoQ revenue drop was attributed to legacy pricing rolling off. From here, realized price tracks a spot market that printed CNY 136,800/t on 2026-07-22 — the lag now works against the P&L.\n- **Restarts are the reason the market broke.** MinRes's Bald Hill (~140,000 dmt SC6/yr, first concentrate expected July 2026) and Core Lithium's Finniss restart add supply into 2027 oversupply expectations, which is what the Guangzhou contract sold off on.\n- **Sell-side has not marked to market.** Consensus on the ASX line is A$15.93 (high A$18.30, low A$14.50) across roughly three analysts with a Buy-skewed consensus, while the ADR closed $60.34 on 2026-08-07 and Macquarie's May 14 2026 ADR-equivalent target was $113.73. A published target roughly 80% above the traded price that price has ignored for two months is not support.\n- **Capex decision into a broken price.** Sanctioning C$366M for the NAL expansion at spot near five-month lows spends the buffer that currently underwrites the story.\n\n## Setup & Price Structure\n- Last completed daily close $60.34 (2026-08-07). Distance from the $102.33 52-week high: −41.0%. Three-month return: −38.4%. RSI(14): 58.8.\n- The RSI/price combination is the whole read. Momentum above the midline with price 41% under the high describes a counter-trend recovery off the July lows, and nothing in the tape yet establishes a higher low that holds. The ADR has not regained its 2026-07-10 level of $62.63.\n- Overhead supply is dated and specific: the May 2026 institutional placement was struck at A$12.20 on the ASX line, and the ASX line traded A$8.86 on 2026-07-11. Placement participants are underwater; that block sits above the market.\n- **Narrative life-cycle: DEAD.** The recovery narrative that ran the name roughly 5x failed on identifiable dates — carbonate's peak CNY 200,500 on 2026-05-13, the break of the A$12.20 placement base by 2026-07-11, the CNY 136,800 five-month low on 2026-07-22, and the 61% QoQ revenue drop reported 2026-07-28. Structure below is broken; what exists now is a bounce, and a new accelerating leg would require the commodity to reclaim the CNY 160,000 area and the equity to build a confirmed higher low first.\n- **Crowding and positioning observables (stated, not judged):** consensus target A$15.93 versus a materially lower traded price, with coverage thin at ~3 analysts; Macquarie's Hold and $113.73 ADR-equivalent target dated 2026-05-14 and unrevised in the context available; A$275M-equivalent of stock issued at A$12.20 in May 2026 into strength that has since reversed; S&P/ASX 200 inclusion at the 2026-06-05 rebalance adding a passive holder base; a hard earnings event inside 30 days. No insider-transaction data is available here, so none is asserted.\n\n## Catalyst Calendar (next 30 days)\n\n- **~2026-08-28 (est.)** — FY26 full-year audited results. The company stated on 2026-07-28 that FY27 guidance will be provided with these results. This is the binary in the window: FY27 volume guidance, unit cost, and whether the C$366M NAL expansion capex is committed or deferred.\n- **~2026-09-30 (est., \"Q3 CY26\")** — completion of the Ewoyaa sale to Zhejiang Huayou Cobalt for ~US$71M cash. May land inside or just beyond the window.\n- No US-style quarterly EPS event exists. Elevra is an Australian issuer with a 30 June year end reporting on Form 6-K; the ADR reflects ASX disclosure with a lag.\n\n## Elapsed catalysts\n\n- **Daily through the window** — Guangzhou Futures Exchange lithium carbonate settlements. The reference levels are the 2026-07-22 five-month low of CNY 136,800/t and that day's CNY 144,000 close. *(passed 18d ago)*\n\n## What Would Change Our Mind\nThe structure that matters is the July shelf on the ADR and the divergence built on it. If the equity resumes tracking carbonate lower — a weekly close below $55 — the July non-confirmation was noise and the downtrend is intact. That is the gradeable break.\n\nTwo secondary conditions would do the same work on fundamentals. First, FY26 full-year results in late August landing with FY27 spodumene guidance below FY26's ~197,968 dmt, or the NAL expansion deferred rather than sanctioned; the catalyst passing without a guidance number at all would leave the name with no dated event until the September-quarter report in late October. Second, the Guangzhou contract closing under the 2026-07-22 low of CNY 136,800/t, which removes the commodity floor the current bounce is standing on.\n\nAbsent that combination, this remains a broken commodity proxy with a strong balance sheet and no accelerating narrative.\n\n## Correlation Notes\n- **Primary driver: China lithium carbonate.** The Guangzhou most-active contract and SMM battery-grade spot set the equity's direction; the 2026-07-22 move to CNY 136,800 and the mid-May high above CNY 200,000 bracket the range the equity has been trading against.\n- **Venue structure.** ASX:ELV in AUD is the price-setting line; ELVR is a thin Nasdaq ADR that can dislocate on low volume and also carries AUD/USD translation. Cross-checking the ADR against the ASX close is necessary before reading any ADR-only move as information.\n- **Peer complex.** Moves correlate with Pilbara Minerals, Liontown, Mineral Resources, Core Lithium, Albemarle and SQM, and with the Canadian hard-rock developers; the 2027 oversupply argument driving the July selloff is a sector-wide input, not company-specific.\n- **Passive flow.** S&P/ASX 200 membership since the 2026-06-05 rebalance ties a share of turnover to index rather than commodity flows.\n- **Reporting currency.** Elevra presents in USD following the change advised with the December 2025 quarterly report, so headline revenue comparisons against older AUD-denominated figures are not like-for-like.",
  "first_seen": "2026-04-22",
  "last_analyzed": "2026-08-08T15:15:19+00:00",
  "last_synthesized": "2026-08-08",
  "last_update_source": "watchlist_research",
  "license": "Content © orbyd. Cite the canonical URL."
}